Venture capital and participation loan – BiotechnologyYsios Capital Partners, SGEIC, SA
Funding | Business angels & venture capital
Ysios Capital Partners invests in initial-stage companies or spin-offs that are seeking an initial round of financing, and focuses on the development of biotechnological and pharmaceutical products, healthcare and medical technology sectors such as devices and diagnoses.
This specialised investment team (made up of scientific partners and administrators and/or with experience in the biotechnological/pharmaceutical sector with a financial/transactional base) starts by reviewing the business plan of the project in question and, if it decides to invest, continues with a comprehensive analysis and the establishment of investment periods.
While in Spain Ysios Capital acts as a main investor in initial rounds of financing, in its main transactions (in the rest of Europe and the United States) it invests in international consortia with other venture capital companies from the sector, thus using and strengthening its global network.
- Average investment size: €4,100,000
- Phase: seed and start-up
- Sector: health industries
- Geographical area: Catalonia, Spain, European Union and the United States
- Instrument: capital and participation loan
- Companies financed: STAT-DIAGNOSTICA, INBIOMOTION
Addressed to: Initial-stage pharmaceutical and biotechnological companies or spin-offs.